02/07/04

HIV drug hurdles in the global south

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>HIV drug hurdles in the global south</h1>
<h4></h4>
</div>
<br />
<br />

<div id="article-body">
<p><P>The efficacy and safety of single pills combining fixed doses of generic drugs as a treatment for HIV infection is emerging from recent research. </P><br />
<P>In this article in <em>The Lancet</em>, N. Kumarasamy summarises the hurdles that must be overcome for the effective implementation of generic antiretroviral therapies in developing countries. These include patients’ adherence to drug regimes, reducing the costs of combination drugs as well as the cost of laboratory analyses, and providing proper training for physicians. </P><br />
<P>Without careful adherence to safety guidelines, antiretroviral drug failure and resistance may arise as a new public health challenge in the future, says Kumarasamy.</P><br />
<P>Reference: <em>The Lancet</em> 364, 3 (2004)</P><br />
<P><a  href="http://www.thelancet.com/journal/vol364/iss9428/full/llan.364.9428.analysis_and_interpretation.30169.1" target="_blank" onclick="pageTracker._trackPageview('/tracking/external/'+this.href);" rel="noopener noreferrer">Link to full article in <EM>The Lancet</EM></A>*<em> </em></P><br />
<P>*Free registration is required to view this article. </P></p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/sub-saharan-africa/opinions/hiv-drug-hurdles-in-the-global-south-ssa/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/sub-saharan-africa/opinions/hiv-drug-hurdles-in-the-global-south-ssa/",null,true])
</script>
</div>

The efficacy and safety of single pills combining fixed doses of generic drugs as a treatment for HIV infection is emerging from recent research.

In this article in The Lancet, N. Kumarasamy summarises the hurdles that must be overcome for the effective implementation of generic antiretroviral therapies in developing countries. These include patients’ adherence to drug regimes, reducing the costs of combination drugs as well as the cost of laboratory analyses, and providing proper training for physicians.

Without careful adherence to safety guidelines, antiretroviral drug failure and resistance may arise as a new public health challenge in the future, says Kumarasamy.

Reference: The Lancet 364, 3 (2004)

Link to full article in The Lancet*

*Free registration is required to view this article.